Laryngeal vs oropharyngeal cancer: T2 or not T2

Oral Oncol. 2020 Oct:109:104678. doi: 10.1016/j.oraloncology.2020.104678. Epub 2020 Apr 7.

¹ Department of Otolaryngology - Head and Neck Surgery, Regina Elena National Cancer Institute, IRCCS, Via Elio Chianesi 53, Rome, Italy.
² Ear Nose and Throat and Audiology Department, University Hospital of Ferrara, Ferrara, Italy.
³ Department of Otolaryngology - Head and Neck Surgery, Regina Elena National Cancer Institute, IRCCS, Via Elio Chianesi 53, Rome, Italy. Electronic address: petruzzigerardo@gmail.com.
⁴ Otorhinolaryngology Unit, Humanitas Clinical and Research Center - IRCCS, Viale Manzoni 56, Rozzano (MI), Italy; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele (MI), Italy.
⁵ Department of Radiation Oncology, IRCSS Regina Elena National Cancer Institute, Rome, Italy.

No abstract available

Keywords: Chemoradiotherapy; Glosso-epiglottic vallecula; Larynx; Oropharynx; Radiotherapy; TNM.

Publication types